121 related articles for article (PubMed ID: 3872162)
1. Malignant lymphoma presenting with prominent splenomegaly. A clinicopathologic study with special reference to intermediate cell lymphoma.
Narang S; Wolf BC; Neiman RS
Cancer; 1985 May; 55(9):1948-57. PubMed ID: 3872162
[TBL] [Abstract][Full Text] [Related]
2. Malignant lymphoplasmacytic lymphoma with prominent splenomegaly (primary lymphoma of the spleen).
Audouin J; Diebold J; Schvartz H; Le Tourneau A; Bernadou A; Zittoun R
J Pathol; 1988 May; 155(1):17-33. PubMed ID: 3379515
[TBL] [Abstract][Full Text] [Related]
3. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
4. Mantle-zone lymphoma: a follicular variant of intermediate lymphocytic lymphoma.
Weisenburger DD; Kim H; Rappaport H
Cancer; 1982 Apr; 49(7):1429-38. PubMed ID: 6895860
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
[TBL] [Abstract][Full Text] [Related]
6. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
[TBL] [Abstract][Full Text] [Related]
7. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
Byrne GE
Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
[TBL] [Abstract][Full Text] [Related]
8. Non-Hodgkin's lymphoma presenting with prominent splenomegaly--clinicopathologic diversity in relationship to immunophenotype.
Nair S; Shukla J; Chandy M
Acta Oncol; 1997; 36(7):725-7. PubMed ID: 9490091
[TBL] [Abstract][Full Text] [Related]
9. Non-Hodgkin's lymphomas of primary follicle/mantle zone origin.
Weisenburger DD
Leukemia; 1991; 5 Suppl 1():26-9. PubMed ID: 1716336
[TBL] [Abstract][Full Text] [Related]
10. [B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum].
Schwarze EW; Pileri S; Stein H; Palestro G; Tolksdorf G
Klin Padiatr; 1982; 194(4):226-32. PubMed ID: 6982372
[TBL] [Abstract][Full Text] [Related]
11. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma.
Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y
Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182
[TBL] [Abstract][Full Text] [Related]
12. [A new functional interpretation of malignant lymphomas. The Lukes-Collins classification and its basis].
Maurer R; Lukes RJ
Schweiz Med Wochenschr; 1979 Jan; 109(3):76-86. PubMed ID: 310578
[TBL] [Abstract][Full Text] [Related]
13. Scanning and transmission electron microscopy of clonal peripheral blood lymphocytes in low grade non-Hodgkin's B-cell lymphomas with predominant splenomegaly.
Soligo D; Quirici N; Caneva L; Baldini L; Cro L; Lambertenghi Deliliers G
Microsc Res Tech; 1994 Jul; 28(4):345-55. PubMed ID: 7919521
[TBL] [Abstract][Full Text] [Related]
14. Fine needle aspiration biopsy of the spleen. A useful procedure in the diagnosis of splenomegaly.
Zeppa P; Vetrani A; Luciano L; Fulciniti F; Troncone G; Rotoli B; Palombini L
Acta Cytol; 1994; 38(3):299-309. PubMed ID: 8191816
[TBL] [Abstract][Full Text] [Related]
15. [Idiopathic splenomegaly: the preliminary stage of a malignant lymphoma? Report on 2 cases].
Stahel RA; Maurer R; Cavalli F; Fehr J
Schweiz Med Wochenschr; 1982 May; 112(20):725-30. PubMed ID: 7100869
[TBL] [Abstract][Full Text] [Related]
16. A critical analysis of the classifications of non-Hodgkin's lymphomas.
Nathwani BN
Cancer; 1979 Aug; 44(2):347-84. PubMed ID: 383253
[TBL] [Abstract][Full Text] [Related]
17. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
Davey FR; Goldberg J; Stockman J; Gottlieb AJ
Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
[TBL] [Abstract][Full Text] [Related]
18. Malignant lymphoma with primary presentation in the spleen. A study of 20 patients.
Spier CM; Kjeldsberg CR; Eyre HJ; Behm FG
Arch Pathol Lab Med; 1985 Dec; 109(12):1076-80. PubMed ID: 3840980
[TBL] [Abstract][Full Text] [Related]
19. [Centroblastic and centrocytic centroblastic malignant lymphomas, predominantly splenic (or primary of the spleen). Anatomo-clinical study of 17 cases].
Diebold J; Kanavaros P; Audouin J; Bernadou A; Zittoun R
Bull Cancer; 1987; 74(4):437-53. PubMed ID: 3663966
[TBL] [Abstract][Full Text] [Related]
20. Clinico-pathologic correlation in non-Hodgkin's lymphoma. I. Retrospective analysis using the Lukes and Collins classification.
Lenner P; Lundgren E; Damber L
Acta Radiol Oncol Radiat Phys Biol; 1979; 18(3):177-91. PubMed ID: 525424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
